HuGE Literature Finder
Records
1
-
5
Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. International journal of oral and maxillofacial surgery 2019 Aug . Guo Z, Cui W, Que L, Li C, Tang X, Liu |
Association between CYP2C8 (rs1934951) polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: a meta-analysis. Acta haematologica 2013 129 (2): 90-5. Zhong Da-Ni, Wu Ji-Zhou, Li Guo-Ji |
CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma. Haematologica 2011 Oct 96 (10): 1557-9. Such Esperanza, Cervera José, Terpos Evangelos, Bagán José V, Avaria Amparo, Gómez Inés, Margaix María, Ibañez Mariam, Luna Irene, Cordón Lourdes, Roig Mónica, Sanz Miguel A, Dimopoulos Meletios A, de la Rubia Javi |
A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer. Therapeutics and clinical risk management 2010 6 579-83. English Bevin C, Baum Caitlin E, Adelberg David E, Sissung Tristan M, Kluetz Paul G, Dahut William L, Price Douglas K, Figg William |
Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.
![]() Blood 2008 Oct 112 (7): 2709-12. Sarasquete Maria E, García-Sanz Ramon, Marín Luis, Alcoceba Miguel, Chillón Maria C, Balanzategui Ana, Santamaria Carlos, Rosiñol Laura, de la Rubia Javier, Hernandez Miguel T, Garcia-Navarro Inmaculada, Lahuerta Juan J, González Marcos, San Miguel Jesus |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: